| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
40,662 |
37,987 |
$4.00M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,732 |
31,093 |
$2.41M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12,511 |
12,383 |
$1.17M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
10,950 |
10,514 |
$951K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
6,761 |
6,552 |
$851K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,839 |
4,788 |
$447K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,540 |
2,179 |
$431K |
| 99499 |
|
15,058 |
14,826 |
$383K |
| 99429 |
|
13,558 |
13,360 |
$323K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,740 |
3,576 |
$192K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,590 |
1,541 |
$146K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,331 |
1,222 |
$142K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,070 |
3,964 |
$125K |
| 99215 |
Prolong outpt/office vis |
597 |
574 |
$90K |
| 99177 |
|
23,405 |
23,070 |
$86K |
| D0120 |
Periodic oral evaluation - established patient |
3,712 |
3,533 |
$78K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
570 |
551 |
$77K |
| D9999 |
Unspecified adjunctive procedure, by report |
3,587 |
3,411 |
$71K |
| 90670 |
|
3,117 |
3,065 |
$44K |
| 90686 |
|
2,738 |
2,694 |
$39K |
| 99188 |
|
2,571 |
2,218 |
$27K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,293 |
1,283 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
223 |
219 |
$19K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
189 |
186 |
$19K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
731 |
725 |
$17K |
| 36416 |
|
4,078 |
3,949 |
$14K |
| 96127 |
|
2,981 |
2,805 |
$13K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
32 |
32 |
$12K |
| D1206 |
Topical application of fluoride varnish |
616 |
589 |
$11K |
| 90633 |
|
754 |
743 |
$11K |
| 99381 |
|
111 |
109 |
$9K |
| 83655 |
|
859 |
831 |
$9K |
| 90680 |
|
671 |
663 |
$9K |
| 90671 |
|
617 |
606 |
$9K |
| 90698 |
|
727 |
723 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
230 |
228 |
$7K |
| E0570 |
Nebulizer, with compressor |
61 |
61 |
$7K |
| 99383 |
|
68 |
67 |
$7K |
| 99382 |
|
70 |
67 |
$7K |
| 90674 |
|
333 |
321 |
$6K |
| 0071A |
|
143 |
142 |
$6K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
840 |
832 |
$5K |
| 96161 |
|
2,713 |
2,641 |
$5K |
| 90836 |
|
103 |
101 |
$5K |
| 0072A |
|
95 |
95 |
$4K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
31 |
30 |
$4K |
| 90744 |
|
332 |
328 |
$3K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
78 |
76 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
49 |
33 |
$3K |
| 0012A |
|
83 |
81 |
$3K |
| 90700 |
|
220 |
218 |
$3K |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$2K |
| 90685 |
|
211 |
208 |
$2K |
| 92522 |
|
37 |
37 |
$2K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
28 |
15 |
$2K |
| 90672 |
|
122 |
120 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
111 |
109 |
$1K |
| 0011A |
|
100 |
98 |
$1K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
26 |
12 |
$1K |
| 85018 |
|
570 |
549 |
$1K |
| 90710 |
|
61 |
60 |
$1K |
| 90707 |
|
80 |
80 |
$1K |
| 92523 |
|
12 |
12 |
$1K |
| 90697 |
|
68 |
67 |
$1K |
| 54150 |
|
32 |
32 |
$1K |
| 0002A |
|
24 |
24 |
$960.00 |
| 90688 |
|
82 |
81 |
$926.09 |
| 90480 |
|
35 |
35 |
$836.00 |
| 87634 |
|
13 |
13 |
$739.86 |
| 88720 |
|
182 |
162 |
$739.05 |
| 97167 |
|
13 |
13 |
$704.73 |
| 90647 |
|
53 |
53 |
$588.28 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
74 |
63 |
$514.15 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
34 |
17 |
$426.88 |
| 90661 |
|
124 |
122 |
$402.38 |
| 91321 |
|
45 |
45 |
$295.61 |
| 90716 |
|
27 |
27 |
$283.03 |
| 90715 |
|
14 |
14 |
$275.66 |
| 90696 |
|
14 |
14 |
$275.66 |
| 90651 |
|
13 |
13 |
$255.97 |
| 90713 |
|
13 |
13 |
$250.18 |
| 90734 |
|
12 |
12 |
$236.28 |
| 90648 |
|
12 |
12 |
$216.59 |
| 81003 |
|
127 |
123 |
$200.69 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
28 |
28 |
$173.50 |
| 99173 |
|
141 |
141 |
$94.57 |
| 90660 |
|
13 |
13 |
$34.06 |
| 99072 |
|
4,320 |
3,537 |
$5.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$1.08 |
| 99000 |
|
498 |
488 |
$0.00 |
| 91301 |
|
38 |
36 |
$0.00 |